IL115861A - Pharmaceutical formulation for the treatment of infants in risk of sudden infant death syndrome - Google Patents

Pharmaceutical formulation for the treatment of infants in risk of sudden infant death syndrome

Info

Publication number
IL115861A
IL115861A IL115861A IL11586192A IL115861A IL 115861 A IL115861 A IL 115861A IL 115861 A IL115861 A IL 115861A IL 11586192 A IL11586192 A IL 11586192A IL 115861 A IL115861 A IL 115861A
Authority
IL
Israel
Prior art keywords
infants
pharmaceutical formulation
risk
treatment
death syndrome
Prior art date
Application number
IL115861A
Inventor
Zisapel Nava
Original Assignee
Neurim Pharma 1991
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11064108&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL115861(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991
Publication of IL115861A publication Critical patent/IL115861A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

A pharmaceutical formulation, for the prevention of sudden infant death syndrome in infants shown to have a deficient plasma melatonin level, which comprises melatonin in combination with at least one pharmaceutical carrier, diluent or coating.
IL115861A 1992-10-11 1992-10-14 Pharmaceutical formulation for the treatment of infants in risk of sudden infant death syndrome IL115861A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL10341192A IL103411A (en) 1992-10-11 1992-10-11 Pharmaceutical formulation for controlled-release of melatonin for use in correcting a melatonin deficiency or distortion in the plasma melatonin level and profile in humans

Publications (1)

Publication Number Publication Date
IL115861A true IL115861A (en) 1997-04-15

Family

ID=11064108

Family Applications (2)

Application Number Title Priority Date Filing Date
IL10341192A IL103411A (en) 1992-10-11 1992-10-11 Pharmaceutical formulation for controlled-release of melatonin for use in correcting a melatonin deficiency or distortion in the plasma melatonin level and profile in humans
IL115861A IL115861A (en) 1992-10-11 1992-10-14 Pharmaceutical formulation for the treatment of infants in risk of sudden infant death syndrome

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL10341192A IL103411A (en) 1992-10-11 1992-10-11 Pharmaceutical formulation for controlled-release of melatonin for use in correcting a melatonin deficiency or distortion in the plasma melatonin level and profile in humans

Country Status (1)

Country Link
IL (2) IL103411A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL144900A (en) 2001-08-14 2013-12-31 Neurim Pharma 1991 Melatonin and medicaments comprising it for use in treating primary insomnia and in the manufacture of such medicaments
CN104840439B (en) * 2014-02-17 2019-07-23 中国科学院上海药物研究所 A kind of bionical drug release preparation of epiphysin and preparation method thereof

Also Published As

Publication number Publication date
IL103411A0 (en) 1993-05-13
IL103411A (en) 1996-11-14

Similar Documents

Publication Publication Date Title
AU4285596A (en) Sudden infant death syndrome prevention apparatus
LU91378I2 (en) Melatonin circadin
FI941452A0 (en) Compounds that increase the antitumor activity of other cytotoxic agents
IL100942A0 (en) 2,4-diaminoquinazoline derivatives for enhancing antitumor activity
NO952237D0 (en) Synthetic catalytic free radical scavengers useful as antioxidants for disease prevention and therapy
HUT67742A (en) Phosphono-oxymethyl-ethers of taxane derivatives
GR3004966T3 (en)
DK0612248T3 (en) Composition containing cisplatin and topotecan as antitumor agent
ZA894392B (en) Pharmaceutical products
GB9212308D0 (en) Therapeutic compositions
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
EP0610519A4 (en) Anti-hiv drug.
AU641279B2 (en) Oligosaccharide derivatives
DK0583026T3 (en)
EP0592903A3 (en) Use of ancrod for the preparation of drugs for the treatment of restenosis.
EP0676951A4 (en) Use of vitamin d glycosides for the treatment or prevention of osteoporosis.
IL115861A (en) Pharmaceutical formulation for the treatment of infants in risk of sudden infant death syndrome
GR3034757T3 (en) Compositons for the treatment of chronic fatigue syndrome.
EP0284405A3 (en) Anti-viral compounds, dosage forms and methods
GR3024028T3 (en) Cytotoxic and antiviral compound.
UA41285C2 (en) Creatine phosphate and pharmaceutically acceptable salts thereof for cancer treatment and pharmaceutical composition possessing anticancer activity
IL107017A0 (en) Thiomarinol derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same
DZ3208A1 (en) Low dose tablets and preparation process.
EP0647135A4 (en) Bis-(substituted-phenyl) derivatives with cytotoxic and anticancer activity.
NZ501365A (en) Use of low-molecular-weight heparins for preventing and treating central nervous system (CNS) trauma

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees
NE Application for restoration - patent lapsed through non-payment of renewal fees (section 60, patents law, 5727-1967)
KB Patent renewed
KB Patent renewed
EXP Patent expired